To take part in these sessions, register to attend SHA 2021:
Register to SHA2021
Friday, 8 October 2021
ESC Arabia Session 1: Cardiac involvement in COVID-19 infection
Chairpersons
Mohammed Balghith (KSA), Susanna Price (UK)
| 08:00-09:30 CEST – Hall 1 |
| 08:00 - 08:20 CEST |
Covid-19 infection and Covid Vaccination: triggers for acute coronary syndromes? |
Alaide Chieffo (Italy) |
| 08:20 - 08:40 CEST |
Pericardial and myocardial involvement in Covid-19 infection |
Marco Metra (Italy) |
| 08:40 - 09:00 CEST |
Cardiac arrhythmias in COVID-19 infection |
Bandar Alghamdi (KSA) |
| 09:00 - 09:20 CEST |
The saga of COVID-19 pharmacologic treatments: what did and did not work out |
Fakhr Alyoubi (KSA) |
| 09:20 - 09:30 CEST |
Discussion |
|
ESC Arabia Session 2: What’s new in the management of atrial fibrillation patients
Chairpersons
Abdulmohsen AlMusaad (KSA), Dipen Shah (Switzerland)
| 12:30-14:00 CEST- Hall 1 |
| 12:31 - 12:51 CEST |
New European guidelines for the diagnosis and management of atrial fibrillation |
Gerhard Hindricks (Germany) |
| 12:31 - 13:11 CEST |
The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): In-depth characterization of atrial fibrillation |
Tatjana Potpara (Serbia) |
| 13:11 - 13:31 CEST |
How to choose the most appropriate non-vitamin K antagonist oral anticoagulants (NOAC) for your atrial fibrillation patient? |
KSA Speaker (tbc) |
| 13:31 - 13:51 CEST |
Rhythm control vs. rate control: a closed debate? |
KSA Speaker (tbc) |
| 13:51 - 14:00 CEST |
Discussion |
|
ESC Arabia Session 3: Research translating into practice changes in acute coronary syndrome
Chairpersons
Khalid Alhabib (KSA), Marco Roffi (Switzerland)
| 14:15-15:45 CEST - Hall 1 |
| 14:15 - 14:35 CEST |
The role of high-sensitivity cardiac troponin in the non-STEMI diagnosis and management |
KSA Speaker (tbc) |
| 14:35 - 14:55 CEST |
Prasugrel preferred over ticagrelor in NSTE-ACS patients undergoing PCI? |
Stefanie Schüpke (Germany) |
| 14:55 - 15:15 CEST |
Complete revascularization is best for most ACS patients with multivessel disease |
KSA Speaker (tbc) |
| 15:15 - 15:35 CEST |
Do patients with anemia presenting with require blood transfusions? |
Jose Ramon Juanatey (Spain) |
Come and meet us on the virtual ESC Stand!
The European Society of Cardiology is the world’s largest organisation of healthcare professionals dedicated to fighting heart disease. Find out what the ESC can do for you, including:
Connect with the ESC
- Create your My ESC Account – your gateway to the ESC. It’s free and available in a few short clicks!
- Want regular updates on ESC science, tools and congresses and education? Subscribe to our newsletters.
About the European Society of Cardiology
The European Society of Cardiology is the world’s largest organisation of healthcare professionals dedicated to fighting heart disease.
Through our global network of 57 National Cardiac Societies and 48 Affiliated Cardiac Societies, we help more than 100,000 clinicians, scientists, nurses and allied professionals expand the boundaries of cardiovascular medicine.
The ESC publishes 16 scientific journals, an array of textbooks and world-renowned ESC Clinical Practice Guidelines. It provides continuing medical education through online programmes, financial support through grants and hosts the summit of cardiovascular science each August – ESC Congress.
Join our community of cardiologists from more than 150 countries. Become an ESC Professional Member.
Our diversity is our strength
Our mission: To reduce the burden of cardiovascular disease.